Addressing US FDA challenges in Indian sterile drug manufacturing – Part 3 Manish Bhatkar Jun 21, 2025 In this final instalment, Manish Bhatkar, Founder & CEO, RedLotus Pharmtech, transitions from analysis to action. Drawing on…
Addressing US FDA challenges in Indian sterile drug manufacturing – Part 2 Manish Bhatkar Jun 20, 2025 In this second part, Manish Bhatkar, Founder & CEO, RedLotus Pharmtech continues the discussion on FDA expectations, with…
